Systemix reports / featured landscape
Batten disease report.
Understand the field.
Know where to act.
From the science to the business case. Explore the evidence, development barriers and opportunities shaping the path to treatment in CLN3.
CLN3 (BATTEN) DISEASE
See the depth.
Find your starting point.
Patient pathways and key centres in EU and US
Where are the patients, and who connects them to care and trials?
Connect the patient pathway with the geography of care, documented treatment and trial sites, and the clinical and scientific experts shaping the field.
- Patient pathway and location
- 60+ treatment centres and trial sites
- Over 300 experts and the clinical ecosystem
CLN2 and CLN3 roles differ. Expert coverage is not a ranked individual KOL directory.
Screenshot-based previews from the supplied report examples.
The full landscape
Connect science,
care and opportunity.
Eleven chapters connect the biology and patient journey to development, regulation, reimbursement, funding and the organisations shaping the field.
A concrete starting point for biotech, pharma and patient organisations. Use the CLN3 landscape to identify evidence gaps, challenge assumptions and make informed decisions.
Discuss how it fits your questionsExplore the report’s scope
Make the landscape work for your next decision
Tell us your programme and the questions you need to answer. We will discuss the report, access and the right scope for your team.